#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antiphospholipid syndrome Skin cancer B-cell lymphoma refractory Neurofibroma Cerebral amyloid angiopathy B-cell small lymphocytic lymphoma recurrent Vulval cancer Familial amyotrophic lateral sclerosis Follicle centre lymphoma follicular grade I II – III refractory Congenital pseudarthrosis Arrhythmogenic right ventricular dysplasia Mucopolysaccharidosis I Pancreatic neuroendocrine tumour Pyruvate kinase deficiency anaemia Chronic myeloid leukaemia More trials…

    Learn about Rare Diseases

    Adrenogenital syndrome – Basic Information Cerebral arteriovenous malformation haemorrhagic – Life with Disease Retinitis pigmentosa – Basic Information Angelman’s syndrome – Treatment Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Glycogen storage disease type II – Trials in Disease Behcet’s syndrome – Basic Information Leiomyosarcoma – Trials in Disease Ewing’s sarcoma recurrent – Trials in Disease Primary hyperoxaluria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ioflupane (123I) Gsk4004280 Neridronate Sodium Briquilimab Tradipitant Tabelecleucel Ifosfamide Bidridistrogene Xeboparvovec Certolizumab Pegol Emraclidine Pegargiminase Metronidazole Pivekimab Sunirine Sodium Hypochlorite Dexchlorpheniramine Maleate Lutetium (177Lu)-Neobomb1 Etravirine Mosunetuzumab Sacubitril Asp1570 More therapies…

    Learn about Your Condition

    Acute on chronic liver failure Peritonitis Gastric cancer recurrent Endocrine ophthalmopathy Ulcerative keratitis Prodromal Alzheimer's disease Subdural haematoma Lupus nephritis Intellectual disability B-cell type acute leukaemia Haemoptysis Deafness neurosensory Erythema Spinal cord injury cervical Sinusitis bacterial More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Evaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Herpes zoster
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Denmark

  • Using 68Ga-FAPI-46 imaging to detect fibrosis in patients with inflammatory diseases such as Crohn’s disease, ulcerative colitis, systemic sclerosis, and lung fibrosis.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Idiopathic inflammatory myopathy
    • Idiopathic pulmonary fibrosis
    • Interstitial lung disease
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands

  • Study of the effect of hyperbaric oxygen therapy on the bacteria in chronic wounds

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Oxygen
    Austria

  • A study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Loratadine
    Bulgaria Germany Poland Spain

  • A safety study of romosozumab in children and adolescents with osteogenesis imperfecta

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • Romosozumab
    Austria Belgium Germany Hungary Italy Slovakia +1

  • A study of onfekafusp alfa and bifikafusp alfa injected into tumors for patients with advanced skin squamous cell cancer who did not respond to or could not tolerate previous treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    Germany Greece Italy Spain
Previous Page
1 2 3 4 5 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!